Target intelligence / Profile preview

Reactive oxygen species and redox-active substrates (ROS)

Target
ROS
Molecular classification
Small molecule, Reactive chemical species, Oxidants
01

Overview

Reactive oxygen species (ROS) and redox-active substrates are a group of highly reactive oxygen-containing molecules, including superoxide, hydrogen peroxide, and the hydroxyl radical, which are generated as natural byproducts of cellular metabolism (Sies et al., 2017). At physiological levels, they function as vital signaling molecules in processes such as cell proliferation, differentiation, and the immune response (Pizzino et al., 2017). However, excessive accumulation leads to oxidative stress, which causes irreversible damage to cellular components like DNA, lipids, and proteins, contributing to the pathogenesis of cancer, cardiovascular diseases, and neurodegeneration (Frijhoff et al., 2015). Pharmacological intervention typically involves the use of antioxidant scavengers or redox-modulating agents designed to neutralize these species or enhance endogenous antioxidant capacity (DrugBank Online, 2024). While targeting ROS has therapeutic potential, challenges include maintaining the delicate balance of redox signaling and avoiding the disruption of essential physiological functions such as the oxidative burst in phagocytes (Sies et al., 2017).

Other names
Free radicalsOxidantsReactive oxygen intermediatesROIRedox-active molecules
02

Mechanism of action

Drugs targeting these species typically act through direct chemical scavenging, where the drug molecule reacts with and neutralizes the reactive species, or by acting as substrates for antioxidant enzymes to restore cellular redox homeostasis (DrugBank Online, 2024; Sies et al., 2017).

03

Biological functions

Cell signalingApoptosisImmune responseHomeostasisProtein foldingSignal transduction
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetesAging
05

Safety considerations

Disruption of essential physiological redox signalingPotential pro-oxidant activity at high dosesInterference with the oxidative burst required for innate immune defenseLack of tissue specificity leading to systemic side effects (Sies et al., 2017; Pizzino et al., 2017)
06

Interacting drugs

N-acetylcysteine

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsGSH/GSSG ratioIsoprostanes (Frijhoff et al., 2015)

Beyond the preview

Go deeper on Reactive oxygen species and redox-active substrates (ROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and redox-active substrates (ROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call